HB0077 - 104th General Assembly (2025-2026)

CONTROLLED SUB-XYLAZINE
Last Action
3/21/2025 - House: Rule 19(a) / Re-referred to Rules Committee
Statutes Amended In Order of Appearance
720 ILCS 570/208  from Ch. 56 1/2, par. 1208
720 ILCS 570/309.1 new  
Synopsis As Introduced
Amends the Illinois Controlled Substances Act. Schedules xylazine as a Schedule III controlled substance. Provides that notwithstanding the scheduling of xylazine as a Schedule III controlled substance, xylazine shall not be considered a controlled substance when: (1) used by licensed Illinois veterinarians dispensing or prescribing for, or administering to, a nonhuman species of a drug containing xylazine that has been approved by the U.S. Food and Drug Administration; (2) used by licensed Illinois veterinarians dispensing or prescribing for, or administering to, a nonhuman species that is permissible under the Federal Food, Drug, and Cosmetic Act; (3) manufactured, distributed, or used as an active pharmaceutical ingredient for manufacturing an animal drug approved under the Federal Food, Drug, and Cosmetic Act; (4) used by a licensed certified euthanasia technician employed by a certified euthanasia agency; or (5) used by a wildlife biologist engaged in legal or authorized fieldwork under the indirect supervision of a veterinarian.
Actions
DateChamberAction
12/16/2024HousePrefiled with Clerk by Rep. Jackie Haas
1/09/2025HouseFirst Reading
1/09/2025HouseReferred to Rules Committee
2/04/2025HouseAssigned to Judiciary - Criminal Committee
2/18/2025HouseHouse Committee Amendment No. 1 Filed with Clerk by Rep. Jackie Haas
2/18/2025HouseHouse Committee Amendment No. 1 Referred to Rules Committee
2/25/2025HouseHouse Committee Amendment No. 1 Rules Refers to Judiciary - Criminal Committee
3/03/2025HouseAdded Co-Sponsor Rep. Amy Elik
3/03/2025HouseAdded Co-Sponsor Rep. Kevin Schmidt
3/03/2025HouseAdded Co-Sponsor Rep. David Friess
3/18/2025HouseAdded Co-Sponsor Rep. Jennifer Sanalitro
3/21/2025HouseRule 19(a) / Re-referred to Rules Committee
3/21/2025HouseHouse Committee Amendment No. 1 Rule 19(c) / Re-referred to Rules Committee